Delisting risk
GridAI Technologies (GRDX)
Orchestrates energy resources for AI data centers while retaining a legacy gastrointestinal drug program.
$3.62
Pre-market+0.11 (+2.99%)
At close$3.52(−1.82%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | −1 |
| 3 | 4 | 9 | 3 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | |
| Research & development | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| 2 | 3 | 9 | 3 | 2 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 2 | 3 | 9 | 3 | 2 | 0 | 1 | 1 | 1 | 0 | 2 | 0 |
| Operating income | −3 | −4 | −9 | −3 | −2 | −1 | −1 | −1 | −1 | −5 | −4 | −3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | −10 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −3 | −4 | −9 | −3 | −2 | −1 | −1 | −1 | −1 | −4 | −4 | −13 |
| Income tax expense | 0 | 0 | −15 | 4 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −3 | −4 | 6 | −8 | −2 | −12 | −1 | −1 | −1 | −4 | −3 | −13 |
| Discontinued operations | 0 | 0 | 0 | −1 | −1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net income | −3 | −4 | 6 | −9 | −3 | −12 | −1 | −1 | −1 | −3 | −4 | −13 |
| EPS, basic | −$9.21 | −$11.48 | $3.12 | −$3.86 | −$0.59 | −$2.59 | −$0.28 | −$0.21 | −$0.75 | −$0.73 | −$0.82 | −$2.01 |
| EPS, diluted | −$9.21 | −$11.48 | $0.38 | −$3.84 | −$0.57 | −$2.59 | −$0.28 | −$0.21 | −$0.75 | −$0.73 | −$0.82 | −$2.01 |
| Weighted average shares, basic | 0 | 0 | 2 | 2 | 5 | 5 | 5 | 5 | 2 | 4 | 4 | 6 |
| Weighted average shares, diluted | 0 | 0 | 15 | 2 | 5 | 5 | 5 | 5 | 2 | 4 | 4 | 6 |
| EBITDA | −3 | −4 | −9 | −3 | −2 | −1 | −1 | −1 | −1 | −4 | −3 | −2 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| EBIT | −3 | −4 | −9 | −3 | −2 | −1 | −1 | −1 | −1 | −5 | −3 | −3 |